Actos
US, Canada and Puerto Rico
Actos (the commercial name for pioglitazone) was approved in 1999 to treat Type II diabetes, a disease that results from the body’s inability to produce enough insulin, or properly use the insulin that is produced.
Manufactured by Takeda Pharmaceuticals , Actos has been associated with bladder cancer when taken over a long period of time or in high doses.
ALERTS & RECALLS
In recent years, Actos has been heavily scrutinized by government officials in the United States and beyond due to the risk of developing Actos bladder cancer when the drug is taken for long periods of time or at high doses.
In September of 2010, the FDA issued a safety alert indicating that the national health agency was reviewing studies that suggested a link between Actos and bladder cancer.
In June of 2011, the FDA issued another safety alert announcing that “use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer” and ordered that Takeda revise Actos labels to prominently feature warnings about this risk.
In 2011, both France and Germany responded to Actos risks by pulling the drug from the market. In July of 2011, Takeda issued a recall of Actos in France, but refused to do the same in the United States.
If you or someone you love used Actos and have been diagnosed with bladder cancer, let our experienced lawyers, specializing in the Actos lawsuit help you get the settlement you deserve.
Call us now at 1-800-RESULTS (1-800-737-8587). Or Email us for more information.
Balkin & Eisbrouch, LLC is a national law firm covering all fifty states as well as Canada, Puerto Rico and all American possessions. No matter where you live, we will have an experienced lawyer, specializing in Actos represent you.
